CPT code 79403 denotes the intravenous infusion of radiolabeled monoclonal antibodies for therapeutic purposes. This code captures a specialized oncology procedure that combines biologic therapy with targeted radiotherapy, supporting treatment regimens for selected malignancies and certain systemic conditions where radioimmunotherapy is indicated. Nationally, accurate coding for this service matters for clinical documentation, care coordination, and payer adjudication given the high-cost, high-complexity nature of radiolabeled biologic infusions.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication presents the clinical context for CPT code 79403, typical sites of care, and the common billing modifiers associated with infusion services. Readers will find concise benchmarks for coding and billing practices, an outline of payer coverage considerations, and an overview of operational implications for infusion centers and oncology clinics. The content is intended to help billing managers, clinicians, and policy analysts understand where this code fits within therapeutic oncology services and what issues commonly arise during claims submission and payer review.